287 related articles for article (PubMed ID: 2971675)
1. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
[TBL] [Abstract][Full Text] [Related]
2. Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen.
Takeuchi T; Rudd CE; Schlossman SF; Morimoto C
Eur J Immunol; 1987 Jan; 17(1):97-103. PubMed ID: 2949986
[TBL] [Abstract][Full Text] [Related]
3. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.
Morimoto C; Steinberg AD; Letvin NL; Hagan M; Takeuchi T; Daley J; Levine H; Schlossman SF
J Clin Invest; 1987 Mar; 79(3):762-8. PubMed ID: 2950134
[TBL] [Abstract][Full Text] [Related]
4. Defects of autologous mixed lymphocyte reaction-activated immunoregulatory T cells in patients with systemic lupus erythematosus.
Koide J; Takeuchi T; Hosono O; Takano M; Abe T
Scand J Immunol; 1987 Oct; 26(4):363-9. PubMed ID: 2961048
[TBL] [Abstract][Full Text] [Related]
5. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
Smolen JS; Siminovitch K; Luger TA; Steinberg AD
Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
[TBL] [Abstract][Full Text] [Related]
6. The isolation and characterization of the human suppressor inducer T cell subset.
Morimoto C; Letvin NL; Distaso JA; Aldrich WR; Schlossman SF
J Immunol; 1985 Mar; 134(3):1508-15. PubMed ID: 3155770
[TBL] [Abstract][Full Text] [Related]
7. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus.
Tanaka S; Matsuyama T; Steinberg AD; Schlossman SF; Morimoto C
Arthritis Rheum; 1989 Apr; 32(4):398-405. PubMed ID: 2523219
[TBL] [Abstract][Full Text] [Related]
8. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases.
Morimoto C; Romain PL; Fox DA; Anderson P; DiMaggio M; Levine H; Schlossman SF
Am J Med; 1988 May; 84(5):817-25. PubMed ID: 2966579
[TBL] [Abstract][Full Text] [Related]
10. The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system.
Takeuchi T; Schlossman SF; Morimoto C
Cell Immunol; 1987 Jun; 107(1):107-14. PubMed ID: 2953440
[TBL] [Abstract][Full Text] [Related]
11. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
Volk HD; Diamantstein T
Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
[TBL] [Abstract][Full Text] [Related]
12. Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen.
Takeuchi T; Rudd CE; Tedder TF; Schlossman SF; Morimoto C
Cell Immunol; 1989 Jan; 118(1):68-84. PubMed ID: 2463098
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the T4+2H4+ cell of peripheral blood lymphocyte in systemic lupus erythematosus].
Jiang M; Sun HY; Zu LP
Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):426-8, 457. PubMed ID: 1684317
[TBL] [Abstract][Full Text] [Related]
14. The isolation and characterization of the human helper inducer T cell subset.
Morimoto C; Letvin NL; Boyd AW; Hagan M; Brown HM; Kornacki MM; Schlossman SF
J Immunol; 1985 Jun; 134(6):3762-9. PubMed ID: 3157750
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells.
Stohl W; Crow MK; Kunkel HG
N Engl J Med; 1985 Jun; 312(26):1671-8. PubMed ID: 2582253
[TBL] [Abstract][Full Text] [Related]
16. The T4 molecule differentially regulating the activation of subpopulations of T4+ cells.
Takeuchi T; Schlossman SF; Morimoto C
J Immunol; 1987 Aug; 139(3):665-71. PubMed ID: 2955047
[TBL] [Abstract][Full Text] [Related]
17. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.
Morimoto C; Hafler DA; Weiner HL; Letvin NL; Hagan M; Daley J; Schlossman SF
N Engl J Med; 1987 Jan; 316(2):67-72. PubMed ID: 2946956
[TBL] [Abstract][Full Text] [Related]
18. Role of the 2H4 molecule in the activation of suppressor inducer function.
Morimoto C; Matsuyama T; Rudd CE; Forsgren A; Letvin NL; Schlossman SF
Eur J Immunol; 1988 May; 18(5):731-7. PubMed ID: 2967762
[TBL] [Abstract][Full Text] [Related]
19. Direct demonstration of immunoregulatory T-cell defects in patients with systemic lupus erythematosus.
Koide J; Takano M; Takeuchi T; Hosono O; Amano K; Homma M; Abe T
Scand J Immunol; 1986 Apr; 23(4):449-59. PubMed ID: 2939553
[TBL] [Abstract][Full Text] [Related]
20. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.
Morimoto C; Reinherz EL; Distaso JA; Steinberg AD; Schlossman SF
J Clin Invest; 1984 Mar; 73(3):689-700. PubMed ID: 6231307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
